Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMTmethylated/DGKImethylated glioblastoma. - Besson JM; Etcheverry A; Nadaradjane A; Bougras-Cartron G; Aubry M; Frenel JS; Chevanieu A; Lopez M; Mosser J; Cartron PF (Clinical epigenetics, 2025)